Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prostate Cancer Metastatic × Radiotherapy × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 47 Glioblastoma 46 Prostatic Neoplasms 44 Carcinoma, Non-Small-Cell Lung 41 Squamous Cell Carcinoma of Head and Neck 32 Head and Neck Neoplasms 24 Lung Neoplasms 22 Neoplasms 20 Rectal Neoplasms 19 Glioma 19 Brain Neoplasms 18 Sarcoma 16 Uterine Cervical Neoplasms 14 Esophageal Neoplasms 13 Pancreatic Neoplasms 12 Neoplasm Metastasis 12 Oropharyngeal Neoplasms 11 Esophageal Squamous Cell Carcinoma 11 Astrocytoma 11 Melanoma 10 Gliosarcoma 10 Triple Negative Breast Neoplasms 9 Colorectal Neoplasms 9 Stomach Neoplasms 8 Radiation Injuries 8 Lymphoma 8 Hodgkin Disease 8 Carcinoma, Squamous Cell 8 Carcinoma, Renal Cell 8 Carcinoma, Hepatocellular 8

Interventions

Radiosurgery 3 Prednisone 2 Docetaxel 2 Androgen Antagonists 2 Abiraterone Acetate 2 fludrocortisone acetate 1 enzalutamide 1 apalutamide 1 Standard of Care 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Pluvicto 1 Lutetium-177 1 Lutetium 1 Hydrocortisone 1 Gonadotropin-Releasing Hormone 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04983095 2026-02-17

METRO

Umeå University

Phase NA Recruiting

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡